Novo Nordisk is shaking up its executive team as it bids adieu to its longtime head of commercial strategy and corporate ...

Novo Nordisk (NVO) said Thursday Camilla Sylvest has decided to leave the company, after a distinguished career of 28 years ...

Bagsværd: Novo Nordisk HA has announced that Camilla Sylvest has decided to leave the company after a distinguished career of ...

Novo Nordisk (NVO) executive Camilla Sylvest is departing the drugmaker after 28 years, Bloomberg’s Sara Sjolin reports. Sylvest has served as ...

This brief covers significant developments in health, including FTC's hold on an insulin lawsuit, Hungary's outbreak control ...

Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an ...

Camilla Sylvest’s caution is possibly to be expected from an executive of a company that, until mid-2022, was known only for its critical but unspectacular business as a maker of insulin and ...

Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday. Denmark welcomes US decision to skip ...

Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the ...

Novo Nordisk (NVO) said Thursday Camilla Sylvest has decided to leave the company, after a distinguished career of 28 years with the drugmaker, seven years as executive vice president of ...

LONDON/COPENHAGEN, April 3 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish ...